Physician profile
Richard C Ostrup
NPI 1780797019
$1,045.80
in general payments reported to CMS, 2019-2025
9 companies · $23.97 in 2025
The $23.97 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2021: $475 · 2022: $40.61 · 2023: $41.70 · 2024: $132 · 2025: $23.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $564.62 | 2019-2021 | |
| Medtronic, INC. | $290.35 | 2021-2025 | Mazor X System, Aquamantys(Tm) |
| Gt Medical Technologies, INC | $50.98 | 2021 | |
| Analogic Corporation | $50.73 | 2019 | |
| Si-Bone, INC. | $24.29 | 2023 | |
| Arbor Pharmaceuticals, INC. | $20.30 | 2019 | |
| Nuvasive, INC. | $17.41 | 2023 | Modulus, Xlif |
| Ethicon US, LLC | $16.03 | 2019 | |
| Misonix INC | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Ostrup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.